Patents by Inventor Anna Segerman

Anna Segerman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Viral vectors for gene therapy
    Patent number: 7459153
    Abstract: Adenovirus types 11p and 4p show a higher binding affinity and infectivity than type 5 for endothelial and carcinoma cell lines. Adenovirus type 11p shows a stronger binding to cells for neural origin, such as glioblastoma, neuroblastoma and medulloblastoma. The fact that adenovirus type 11 has a comparatively low prevalence in society, together with its high affinity and infectivity, makes it very suitable for use in gene therapy.
    Type: Grant
    Filed: January 4, 2002
    Date of Patent: December 2, 2008
    Inventors: Göran Wadell, Ya-fang Mei, Anna Segerman, Johan Skog, Kristina Lindman
  • Viral vectors for gene therapy
    Publication number: 20040136958
    Abstract: Adenovirus types 11p and 4p show a higher binding affinity and infectivity than type 5 for endothelial and carcinoma cell lines. Adenovirus type 11p shows a stronger binding to cells for neural origin, such as glioblastoma, neuroblastoma and medulloblastoma. The fact that adenovirus type 11 has a comparatively low prevalence in society, together with its high affinity and infectivity, makes it very suitable for use in gene therapy.
    Type: Application
    Filed: January 23, 2004
    Publication date: July 15, 2004
    Inventors: Goran Wadell, Ya-fang Mei, Anna Segerman, Johan Skog, Kristina Lindman